Soviero Asset Management, LP Organon & Co. Transaction History

Soviero Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $2.22 Million - $2.72 Million	-70,000 Reduced 14.89%	400,000 $13.5 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $2.13 Million - $2.76 Million	-70,000 Reduced 12.96%	470,000 $16.4 Million
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $6.88 Million - $8.9 Million	-239,800 Reduced 30.75%	540,000 $16.4 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $10.2 Million - $12.8 Million	357,977 Added 84.86%	779,800 $25.6 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $12 Million - $16 Million	421,823 New	421,823 $12.8 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Soviero Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Soviero Asset Management, LP with notifications on news.